MüllerMDLyrerPABrownMM, et al. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Stroke. 2021;52(1):e3-e5.
2.
XinWYangSLiQ, et al. Endarterectomy versus stenting for the prevention of periprocedural stroke or death in patients with symptomatic or asymptomatic carotid stenosis: a meta-analysis of 10 randomized trials. Ann Transl Med. 2021;9(3):256.
3.
HallidayABulbuliaRBonatiLH, et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet. 2021;398(10305):1065-1073.
4.
LiuZJFuWGGuoZY, et al. Updated systematic review and meta-analysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. Ann Vasc Surg. 2012;26(4):576-590.
5.
KotsugiMTakayamaKMyouchinK, et al. Carotid artery stenting: investigation of plaque protrusion incidence and prognosis. JACC Cardiovasc Interv. 2017;10(8):824-831.
6.
SetacciFSirignanoPGalzeranoG, et al. Carotid restenosis after endarterectomy and stenting: a critical issue?. Ann Vasc Surg. 2013;27(7):888-893.
7.
BrottTGHobsonRWIIHowardG, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23. Erratum in: N Engl J Med. 2010;363(5):498. Erratum in: N Engl J Med. 2010;363(2):198.
8.
YadavJSWholeyMHKuntzRE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493-1501.
9.
MozesGSullivanTMTorres-RussottoDR, et al. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg. 2004;39(5):958-965; discussion 965-966.
10.
MazurekAMalinowskiKSirignanoP, et al. Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes. J Cardiovasc Surg. 2023;64(6):570-582.
11.
FokkemaMVrijenhoekJEDen RuijterHM, et al. Stenting versus endarterectomy for restenosis following prior ipsilateral carotid endarterectomy: an individual patient data meta-analysis. Ann Surg. 2015;261(3):598-604.
12.
KökMRöderFBokkersRPH, et al. A systematic review and meta-analysis of outcome after repeat revascularization for primary carotid artery restenosis. J Endovasc Ther. 2025;2025:15266028251325054.
13.
LalBKBeachKWRoubinGS, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol. 2012;11(9):755-763.
14.
BonatiLHDobsonJFeatherstoneRL, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015;385(9967):529-538.
15.
KumarRBatchelderASaratzisA, et al. Restenosis after carotid interventions and its relationship with recurrent ipsilateral stroke: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2017;53(6):766-775.
16.
TocciGBarbatoEColucciaR, et al. Blood pressure levels at the time of percutaneous coronary revascularization and risk of coronary in-stent restenosis. Am J Hypertens. 2016;29(4):509-518.
17.
KoekMMCD’OriaMRöderF, et al. Carotid calcium burden and perivascular fat density on computed tomography angiography as predictors of outcomes after carotid endarterectomy. J Vasc Surg. 2025;82(6):2079-2089.
18.
ZhangLChaiYJiaoZ, et al. Risk factors for restenosis following carotid endarterectomy in patients with full collapse carotid near occlusion. J Vasc Surg. 2026;83(1):131-138.
19.
TopakianRSonnbergerMNussbaumerK, et al. Postprocedural high-density lipoprotein cholesterol predicts carotid stent patency at 1 year. Eur J Neurol. 2008;15(2):179-184.
20.
WasserKSchnaudigelSWohlfahrtJ, et al. Inflammation and in-stent restenosis: the role of serum markers and stent characteristics in carotid artery stenting. PLoS One. 2011;6(7):e22683.
21.
StabileEde DonatoGMusialekP, et al. Use of dual-layered stents for carotid artery angioplasty: 1-year results of a patient-based meta-analysis. JACC Cardiovasc Interv. 2020;13(14):1709-1715.
PakalaRWillersonJTBenedictCR.Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation. 1997;96(7):2280-2286.
24.
MianoJMVlasicNTotaRRStemermanMB.Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am J Pathol. 1993;142(3):715-724.
25.
McCabeDJPereiraACCliftonA, et al. Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS). Stroke. 2005;36(2):281-286.
26.
BonatiLHEderleJMcCabeDJ, et al. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol. 2009;8(10):908-917.
27.
MasJLChatellierGBeyssenB, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16):1660-1671.
28.
ArquizanCTrinquartLTouboulPJ, et al. Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke. 2011;42(4):1015-1020.
29.
BonatiLHGregsonJDobsonJ, et al. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. Lancet Neurol. 2018;17(7):587-596.
30.
MazurekAMalinowskiKRosenfieldK, et al. Clinical outcomes of second- versus first-generation carotid stents: a systematic review and meta-analysis. J Clin Med. 2022;11(16):4819.
31.
StabileEde DonatoGMusialekP, et al. Use of dual-layered stents in endovascular treatment of extracranial stenosis of the internal carotid artery: results of a patient-based meta-analysis of 4 clinical studies. JACC Cardiovasc Interv. 2018;11(23):2405-2411.
32.
SetacciCChisciESetacciF, et al. Grading carotid intrastent restenosis: a 6-year follow-up study. Stroke. 2008;39(4):1189-1196.
33.
AbuRahmaAFAvgerinosEDChangRW, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2022;75(1S):4S-22S.
34.
NaylorRRantnerBAncettiS, et al. Editor’s Choice—European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg. 2023;65(1):7-111.
35.
LanzaGOrsoMAlbaG, et al. Guideline on carotid surgery for stroke prevention: updates from the Italian Society of Vascular and Endovascular Surgery. A trend towards personalized medicine. J Cardiovasc Surg. 2022;63(4):471-491.
36.
KhanMALiuMWChioFL, et al. Predictors of restenosis after successful carotid artery stenting. Am J Cardiol. 2003;92(7):895-897.
37.
MehranRDangasGAbizaidAS, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100(18):1872-1878.
38.
SetacciCde DonatoGSetacciF, et al. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon. Eur J Vasc Endovasc Surg. 2005;29(6):601-607.
39.
CoscasRRhissassiBGruet-CoquetN, et al. Open surgery remains a valid option for the treatment of recurrent carotid stenosis. J Vasc Surg. 2010;51(5):1124-1132.
40.
StiloFSirignanoPMontelioneN, et al. Bypass for symptomatic in-stent carotid restenosis. Int J Cardiol. 2017;249:392-395.
41.
ReichmannBLvan LaanenJHde VriesJP, et al. Carotid endarterectomy for treatment of in-stent restenosis after carotid angioplasty and stenting. J Vasc Surg. 2011;54(1):87-92.
42.
de BorstGJZanenPde VriesJP, et al. Durability of surgery for restenosis after carotid endarterectomy. J Vasc Surg. 2008;47(2):363-371.
YamagamiHSakaiNMatsumaruY, et al. Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS). J Stroke Cerebrovasc Dis. 2012;21(3):193-199.
45.
GalyfosGGeropapasGSigalaF, et al. Meta-analysis of studies evaluating the effect of cilostazol on major outcomes after carotid stenting. J Endovasc Ther. 2016;23(1):186-195.
46.
YamagamiHOzakiTOgasawaraK, et al. Randomized controlled trial of cilostazol addition for in-stent restenosis after carotid artery stenting. Stroke. 2024;55(12):2776-2785.
47.
SunJWangDZhaoY, et al. Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis. J Cardiothorac Surg. 2025;20(1):275.
48.
TakahashiSOidaKFujiwaraR, et al. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol. 1992;20(6):900-906.
49.
KimuraYTaniTKanbeT, et al. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung. 1985;35(7A):1144-1149.
50.
NakagawaIKotsugiMYokoyamaS, et al. Antithrombotic therapy in carotid artery and intracranial artery stent. J Neuroendovasc Ther. 2025;19(1):2024-0014.